Professor Gerald Denis, a molecular oncologist at Boston Medical Center, investigates a range of cancers and their causes. Some of his important studies include prostate cancer and breast cancer, which are increasing today. He focuses on relationships between specific factors such as metabolic conditions (e.g., obesity and diabetes) and certain types of cancer.
In this presentation, Dr. Denis explains how cancer research works, the international influence of American cancer research, and how the recent federal (NIH) defunding sets back the progress in cancer treatment at a time when cancers are increasing.
Gerald Denis, Ph.D., is a molecular oncologist at Boston Medical Center. He is Co-director of the BU BMC Cancer Center and is a charter member of the Tumor Microenvironment Study Section at NIH. Much of his research is focused on how metabolic conditions like obesity and diabetes can influence whether someone develops cancer. Dr. Denis is distinguished especially for his pioneering studies of the Bromodomain and ExtraTerminal (BET) protein family that is important for cellular growth in leukemia, and metastasis of breast and prostate cancers.
